A judge has put a climate change class action on behalf of Torres Strait Islanders on a tight timetable and committed herself to handing down judgment soon after trial, saying the case was one of “considerable urgency”.
Shine and Phi Finney McDonald’s fallback plan to cooperatively run a class action against Nuix has come under fire, with the technology company urging the court to make the two firms compete against one another for sole carriage.
The lead applicants in a climate change class action by Torres Strait Islanders are hoping the Commonwealth will admit climate change targets set by the Morrison government were “woefully inadequate”, a court heard Friday.
In the latest round of finger-pointing in a consolidated shareholder class action against Noumi, formerly Freedom Foods, the food company has taken aim at Deloitte’s claims that it gave the accounting firm misleading information.
A litigation funder has reaped $7.5 million from the sale of a 20 per cent stake in a shareholder class action against the Commonwealth Bank of Australia over the bank’s allegedly lax money laundering compliance.
Apple and Google have been hit with class actions alleging they violated competition laws by charging customers inflated commission on certain apps and in-app purchases.
The ruling by the Full Federal Court that funded class actions are not managed investment schemes marks the end of an ill-considered regime enacted by the Morrison government to rein in class actions, but the debate over regulation of litigation funders is not over yet.
A victor remains to be crowned following a heated beauty parade between competing class actions against tech company Nuix, with two law firms facing criticism for their “cumbrous” consolidation proposal and a third firm copping flak for its “opaque” financials.
A judge has allowed two law firms to jointly run a consolidated shareholder class action against dairy company a2 Milk, saying the arrangement was in the interests of group members and was “not novel”.
Regenerative medicine company Mesoblast has been hit with a second class action for allegedly misleading shareholders about it Remestemcel-L treatment for COVID-19 complications.